Liver Conditions Specific to Pregnancy: Optimizing Management and Outcomes
Open Access
- 8 April 2026
- journal article
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (6) , 646-656
Abstract
Pregnancy is accompanied by complex physiological adaptations that influence hepatic metabolism, bile transport, coagulation, and immune tolerance, which may precipitate the development of pregnancy-specific liver disorders. Gestational liver disease comprises a distinct group of conditions such as hyperemesis gravidarum (HG), intrahepatic cholestasis of pregnancy (ICP), acute fatty liver of pregnancy (AFLP), and the spectrum of preeclampsia that includes hepatic involvement and Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Although heterogeneous in presentation and pathophysiology, these disorders share the potential for significant maternal and fetal morbidity and mortality. Early recognition and hepatology-guided interpretation of abnormal liver biochemistry during pregnancy are critical to differentiate gestational liver disease from underlying chronic liver disease and to identify conditions that require urgent intervention. Management of gestational liver disease requires coordinated, multidisciplinary care focused on maternal stabilization, appropriate disease-specific therapy, and carefully timed delivery according to both maternal and fetal risk. Treatment strategies range from supportive and nutritional management for HG, biochemical and symptom control with ursodeoxycholic acid for ICP, and urgent delivery and intensive supportive care for AFLP to delivery with antihypertensive and anticonvulsant therapy for hypertensive disorders and HELLP syndrome. Although each condition poses unique diagnostic and therapeutic challenges, complications associated with gestational liver disease in pregnancy may be reduced through proactive management and multidisciplinary involvement. This review summarizes current evidence on the pathophysiology, diagnostic evaluation, management strategies, and pregnancy outcomes associated with pregnancy-specific liver disorders. Cite this article as: Frolkis A, Ergenc I, Heneghan MA. Liver conditions specific to pregnancy: optimizing management and outcomes. Turk J Gastroenterol. Published online April 8, 2026. doi: 10.5152/tjg.2026.26024.Keywords
This publication has 90 references indexed in Scilit:
- Increased concentration of the free β‐subunit of human chorionic gonadotropin in hyperemesis gravidarumActa Obstetricia et Gynecologica Scandinavica, 1994
- Wernicke's encephalopathy in hyperemesis gravidarum: association with abnormal liver function.1994
- [Liver complications in HELLP syndrome].1994
- A prospective study of nausea and vomiting during pregnancy.1993
- Abnormal Liver Enzymes and Ketonuria in Hyperemesis Gravidarum A Retrospective Review of 80 PatientsJournal of Clinical Gastroenterology, 1990
- Fulminant Hepatic Failure Caused by Acute Fatty Liver of Pregnancy Treated by Orthotopic Liver TransplantationHepatology, 1990
- TOTAL PARENTERAL-NUTRITION FOR THE TREATMENT OF SEVERE HYPEREMESIS GRAVIDARUM - MATERNAL NUTRITIONAL EFFECTS AND FETAL-OUTCOME1988
- Cholestasis of Pregnancy: Clinical and Laboratory StudiesActa Obstetricia et Gynecologica Scandinavica, 1986
- Recurrent jaundice caused by recurrent hyperemesis gravidarum.Gut, 1984
- Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancyAmerican Journal of Obstetrics and Gynecology, 1982